A Phase I study of cyclin-dependent kinase inhibitor, AT7519, in patients with advanced cancer: NCIC Clinical Trials Group IND 177.

A Phase I study of cyclin-dependent kinase inhibitor, AT7519, in patients with advanced cancer: NCIC Clinical Trials Group IND 177.

Item
http://www.wikidata.org/entity/Q34687067
Targeting cell cycle regulators in hematologic malignancies.Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent NeuroblastomaCDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression.Genetic and pharmacological inhibition of CDK9 drives neutrophil apoptosis to resolve inflammation in zebrafish in vivo.Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.Investigational drugs targeting cyclin-dependent kinases for the treatment of cancer: an update on recent findings (2013-2016).Inhibitors of cyclin-dependent kinases as cancer therapeutics.Novel Pieces for the Emerging Picture of Sulfoximines in Drug Discovery: Synthesis and Evaluation of Sulfoximine Analogues of Marketed Drugs and Advanced Clinical Candidates.Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma.The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group.
P2860

A Phase I study of cyclin-dependent kinase inhibitor, AT7519, in patients with advanced cancer: NCIC Clinical Trials Group IND 177.

Item
http://www.wikidata.org/entity/Q34687067
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A Phase I study of cyclin-depe ...... Clinical Trials Group IND 177.
@ast
A Phase I study of cyclin-depe ...... Clinical Trials Group IND 177.
@en
A Phase I study of cyclin-depe ...... Clinical Trials Group IND 177.
@nl
type
label
A Phase I study of cyclin-depe ...... Clinical Trials Group IND 177.
@ast
A Phase I study of cyclin-depe ...... Clinical Trials Group IND 177.
@en
A Phase I study of cyclin-depe ...... Clinical Trials Group IND 177.
@nl
prefLabel
A Phase I study of cyclin-depe ...... Clinical Trials Group IND 177.
@ast
A Phase I study of cyclin-depe ...... Clinical Trials Group IND 177.
@en
A Phase I study of cyclin-depe ...... Clinical Trials Group IND 177.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
A Phase I study of cyclin-depe ...... Clinical Trials Group IND 177.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698
P921
P932